Utility of the AngelMed Guardian System in myocardial bridging: a case report

Autor: Lakshmi Rao, Arjun Chadha, Anila Rao, Anurag Khandavalli, Surya Rao

Publikováno v: The Egyptian Heart Journal, Vol 76, Iss 1, Pp 1-3 (2024)

Abstract Background Myocardial bridging (MB) is a known congenital anomaly in which a segment of the coronary artery transverses from the epicardium through the myocardium. MB may clinically manifest as recurrent angina, acute coronary syndrome, vent

Externí odkaz: https://doaj.org/article/07661f94c70e4c3ab6fd3fdda2a9e25d

The AngelMed Guardian® System in the Detection of Coronary Artery Occlusion: Current Perspectives

Autor: Kazmi SHA, Datta S, Chi G, Nafee T, Yee M, Kalia A, Sharfaei S, Shojaei F, Mirwais S, Gibson CM

Publikováno v: Medical Devices: Evidence and Research, Vol Volume 13, Pp 1-12 (2020)

Syed Hassan Abbas Kazmi, Sudarshana Datta, Gerald Chi, Tarek Nafee, Megan Yee, Akshun Kalia, Sadaf Sharfaei, Fahimehalsadat Shojaei, Sabawoon Mirwais, C Michael Gibson Division of Cardiovascular Medicine, Department of Medicine, Beth Israel Deaconess

Externí odkaz: https://doaj.org/article/27961046d9c740df8c3101a10ad370b4

McLaren Macomb Medical Center Researchers Yield New Data on Chest Pain (Utility of the AngelMed Guardian System in myocardial bridging: a case report).

Publikováno v: Medical Devices & Surgical Technology Week; 11/3/2024, p662-662, 1p

The AngelMed Guardian ^® System in the Detection of Coronary Artery Occlusion: Current Perspectives.

Autor: Kazmi SHA; Division of Cardiovascular Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Datta S; Division of Cardiovascular Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Chi G; Division of Cardiovascular Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Nafee T; Division of Cardiovascular Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Yee M; Division of Cardiovascular Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Kalia A; Division of Cardiovascular Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Sharfaei S; Division of Cardiovascular Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Shojaei F; Division of Cardiovascular Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Mirwais S; Division of Cardiovascular Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Gibson CM; Division of Cardiovascular Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Publikováno v: Medical devices (Auckland, N.Z.) [Med Devices (Auckl)] 2020 Jan 07; Vol. 13, pp. 1-12. Date of Electronic Publication: 2020 Jan 07 (Print Publication: 2020).

Overview of the 2016 US Food and Drug Administration Circulatory System Devices Panel Meeting on the AngelMed Guardian System

Autor: Ron Waksman, Toby Rogers, Rebecca Torguson, Arie Steinvil

Publikováno v: Circulation. 134:262-264

On March 16, 2016, the US Food and Drug Administration (FDA) convened a meeting of the Circulatory System Devices Panel to consider a premarket approval application for the AngelMed Guardian System based on the results of the pivotal ALERTS trial (An

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a2e38662bd81bfd6b65d1046f2c85d2d
https://doi.org/10.1161/circulationaha.116.023081